Ethics FORUM Elizabeth A. Kitsis, MD, MBE, Michele Meltzer, MD, MBE, and C. Ronald MacKenzie, MD | January 17, 2011Understanding the challenges in rheumatology today
Immunizations and Autoimmune Disease Vanessa Caceres | December 1, 2010What is safe and what to avoid in this patient population
No Clear Connection Between Inflammation & Disease Progression in AS Kathy Holliman | October 1, 2010TNF blockers decrease symptoms but seem to have little impact on structural damage
Are We Playing It Safe? Anja Strangfeld, MD, and Angela Zink, PhD | October 1, 2010Tumor necrosis factor alpha inhibition and the risk of solid malignancies
Meet the Model Biologics Policy From the College | July 1, 2010At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.
Tracking Patient Manifestations of Behçet’s Syndrome around the World Yusuf Yazici, MD | July 1, 2010Tracking patient manifestations of Behçet’s syndrome around the world
RA Therapy Can Increase Risk for Lung Disease Kathy Holliman | April 1, 2010Vigilant screening for NTM lung disease and latent tuberculosis needed
Cochrane Launches Journal Club with RA Article From the College | February 1, 2010Overview of studies on biologic use kicks off monthly literature review feature
Sex Differences & Rheumatoid Arthritis Tuulikki Sokka, MD, PhD | December 1, 2009The beliefs versus the data